Definitive Contract 75N91024C00082

Award Date 9/16/24
Potential Completion Date 9/15/25
Potential Value $455K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Morgantown, WV 26505, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
15
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Cancer Institute (NCI) awarded a Firm Fixed Price Definitive Contract to Navipoint Genomics LLC, a minority-owned small business, under the SBIR Program Phase II. The contract, valued at $1,679,321.00, is for the development of cloud-based software to support the Cancer Research Data Commons project. This project aims to enable precision oncology by facilitating collaboration in the cloud. The contract has a completion date of May 31, 2025 and is set aside for small businesses.
<p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $1,416,758.40 Cost Plus Fixed Fee contract to Sensopath Technologies, Inc., a Woman Owned Small Business, for a Small Business Innovation Research (SBIR) Program Phase II action. The contract, which has a total small business set aside, was awarded on September 28, 2012 with an ultimate completion date of May 22, 2015. The contract delivers research and development services under the SBIR program.</p>
<p>The National Cancer Institute (NCI) awarded a $199,996.00 Firm Fixed Price contract to Operational Technologies Corporation, a minority-owned, small disadvantaged, veteran-owned business, for Research &amp; Development in Biomedical Basic Research. The contract has a completion date of June 22, 2014 and was set aside for small businesses. As a civilian agency, the NCI focuses on cancer research and this contract contributes to their broader medical research initiatives.</p>
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute (NCI) to Inlighta Biosciences L.L.C., a woman-owned small business. The $298,230.00 firm fixed-price contract is for a Phase I Small Business Innovation Research (SBIR) project titled &quot;Non-Invasive Subtyping of Aggressive Tumor and Its Environment&quot; as part of the NCI Cancer Moonshot initiative. The original solicitation was issued under the NIH/CDC...
This is a $398,604.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded to Infotech Soft, Inc. (a woman-owned for-profit organization) by the National Cancer Institute. The contract is for the development of quantitative imaging software tools to assist with cancer diagnosis and treatment planning. The contract is a definitive, firm fixed-price agreement, indicating a well-defined scope of work. This SBIR award is part of the National Cancer Institute's efforts to...
This definitive firm fixed price contract for $246,378 was awarded by the National Institutes of Health National Cancer Institute to Biodepot LLC, a small disadvantaged, woman-owned business. It responds to Topic 407 of the SBIR Phase I solicitation seeking proposals for cloud-based software to support the Cancer Research Data Commons. Placed of performance will be in Seattle, Washington. The SBIR program aims to stimulate technological innovation to meet federal research needs through awards to...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Phenomapper, LLC, a minority-owned, self-certified small disadvantaged business located in San Jose, California. The $398,952.00 firm-fixed-price contract was awarded on September 16, 2020, with a completion date of September 15, 2021. The contract is for the development of artificial intelligence-aided imaging technology...
This is a federal contract award by the National Cancer Institute (NCI), a civilian agency, to Sophic Systems Alliance Inc., a small business veteran-owned contractor. The contract is for a System to Analyze and Support Biomarker Research and Development Strategies under the Small Business Innovation Research (SBIR) Program Phase II. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, with a ceiling value of $745,999.90 and a period of performance ending on August...
This $399,951 firm-fixed-price definitive contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the small business Care Progress LLC. The contract supports the development of &quot;BIOMARKERAWARE: A NOVEL SYSTEM TO IMPROVE PRECISION ONCOLOGY&quot; under the NCI's Small Business Innovation Research (SBIR) program, which is a set-aside for small businesses. Care Progress LLC, a for-profit limited liability company, has previously...
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), awarded a $453,123 Small Business Innovation Research (SBIR) Phase I contract to Pistevo Decision LLC, a minority-owned small business, to develop an integrated multi-level decision support platform to address patient-centered and evidence-based social determinants of health among cancer patients. This Phase I contract is part of a two-year $2 million SBIR Phase II award granted to Pistevo in September 2023....

The National Cancer Institute (NCI) awarded a $455,000.00 Firm Fixed Price Definitive Contract to Sostos Inc., a minority-owned, woman-owned small disadvantaged business. This Phase I contract is a Small Business Set Aside to develop a network-based multimodal data analysis cloud software for cancer biomarker discovery and drug development. The project, titled "TOPIC 464 PHASE I AWARD: NETWORK-BASED MULTIMODAL DATA ANALYSIS CLOUD SOFTWARE FOR CANCER BIOMARKER DISCOVERY AND DRUG DEVELOPMENT," has a completion date of September 15, 2025. Sostos Inc. is an innovative small business with expertise in advanced biomedical technology and artificial intelligence solutions focused on cancer research and diagnostics. The contract award demonstrates the company's capability to create sophisticated computational tools that support cancer research methodologies utilizing cloud-based software and artificial intelligence technologies.

Generated 2/1/25, 9:17 AM